These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 19398719)
21. BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML). Santamaría C; Chillón MC; García-Sanz R; Pérez C; Caballero MD; Mateos MV; Ramos F; de Coca AG; Alonso JM; Giraldo P; Bernal T; Queizán JA; Rodríguez JN; Puig N; Balanzategui A; Sarasquete ME; Alcoceba M; Díaz-Mediavilla J; San Miguel J; González M Ann Hematol; 2010 May; 89(5):453-8. PubMed ID: 19943049 [TBL] [Abstract][Full Text] [Related]
22. Improved classification of MLL-AF9-positive acute myeloid leukemia patients based on BRE and EVI1 expression. Noordermeer SM; Monteferrario D; Sanders MA; Bullinger L; Jansen JH; van der Reijden BA Blood; 2012 May; 119(18):4335-7. PubMed ID: 22555662 [No Abstract] [Full Text] [Related]
23. MLL-rearranged acute myeloid leukemia: Influence of the genetic partner in allo-HSCT response and prognostic factor of MLL 3' region mRNA expression. Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Carrillo E; Sánchez J; Pérez-López O; Pérez de Soto I; González Campos J; Prats-Martín C; Bernal R; Vargas MT Eur J Haematol; 2018 May; 100(5):436-443. PubMed ID: 29384595 [TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Steudel C; Wermke M; Schaich M; Schäkel U; Illmer T; Ehninger G; Thiede C Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922 [TBL] [Abstract][Full Text] [Related]
25. Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: a Cancer and Leukemia Group B study. Marcucci G; Baldus CD; Ruppert AS; Radmacher MD; Mrózek K; Whitman SP; Kolitz JE; Edwards CG; Vardiman JW; Powell BL; Baer MR; Moore JO; Perrotti D; Caligiuri MA; Carroll AJ; Larson RA; de la Chapelle A; Bloomfield CD J Clin Oncol; 2005 Dec; 23(36):9234-42. PubMed ID: 16275934 [TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Renneville A; Boissel N; Nibourel O; Berthon C; Helevaut N; Gardin C; Cayuela JM; Hayette S; Reman O; Contentin N; Bordessoule D; Pautas C; Botton Sd; Revel Td; Terre C; Fenaux P; Thomas X; Castaigne S; Dombret H; Preudhomme C Leukemia; 2012 Jun; 26(6):1247-54. PubMed ID: 22289988 [TBL] [Abstract][Full Text] [Related]
27. The closely related rare and severe acute myeloid leukemias carrying EVI1 or PRDM16 rearrangements share singular biological features. Eveillard M; Delaunay J; Richebourg S; Lodé L; Garand R; Wuillème S; Duhoux F; Antoine-Poirel H; Godon C; Béné MC Haematologica; 2015 Mar; 100(3):e114-5. PubMed ID: 25740106 [No Abstract] [Full Text] [Related]
28. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases. Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804 [TBL] [Abstract][Full Text] [Related]
29. EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia. Balgobind BV; Lugthart S; Hollink IH; Arentsen-Peters ST; van Wering ER; de Graaf SS; Reinhardt D; Creutzig U; Kaspers GJ; de Bont ES; Stary J; Trka J; Zimmermann M; Beverloo HB; Pieters R; Delwel R; Zwaan CM; van den Heuvel-Eibrink MM Leukemia; 2010 May; 24(5):942-9. PubMed ID: 20357826 [TBL] [Abstract][Full Text] [Related]
30. A murine model of acute myeloid leukemia with Evi1 overexpression and autocrine stimulation by an intracellular form of GM-CSF in DA-3 cells. Cardona ME; Simonson OE; Oprea II; Moreno PM; Silva-Lara MF; Mohamed AJ; Christensson B; Gahrton G; Dilber MS; Smith CI; Arteaga HJ Leuk Lymphoma; 2016; 57(1):183-92. PubMed ID: 25907616 [TBL] [Abstract][Full Text] [Related]
31. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H; N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602 [TBL] [Abstract][Full Text] [Related]
32. Expression of CD4 is correlated with an unfavorable prognosis in wild-type NPM1, FLT3-ITD-negative cytogenetically normal adult acute myeloid leukemia. Guo RJ; Atenafu EG; Schimmer AD; Minden MD; Chang H Int J Lab Hematol; 2017 Aug; 39(4):429-437. PubMed ID: 28318150 [TBL] [Abstract][Full Text] [Related]
33. High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia. Hecht A; Nowak D; Nowak V; Hanfstein B; Faldum A; Büchner T; Spiekermann K; Sauerland C; Lengfelder E; Hofmann WK; Nolte F Ann Hematol; 2013 Apr; 92(4):443-9. PubMed ID: 23250622 [TBL] [Abstract][Full Text] [Related]
34. High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics. Heuser M; Beutel G; Krauter J; Döhner K; von Neuhoff N; Schlegelberger B; Ganser A Blood; 2006 Dec; 108(12):3898-905. PubMed ID: 16912223 [TBL] [Abstract][Full Text] [Related]
35. BAALC and ERG expression levels at diagnosis have no prognosis impact on acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Zhang J; Shi J; Zhang G; Zhang X; Yang X; Yang S; Wang J; Ke X; Fu L Ann Hematol; 2018 Aug; 97(8):1391-1397. PubMed ID: 29696374 [TBL] [Abstract][Full Text] [Related]
36. Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia. Fisser MC; Rommer A; Steinleitner K; Heller G; Herbst F; Wiese M; Glimm H; Sill H; Wieser R Mol Carcinog; 2015 Dec; 54(12):1815-9. PubMed ID: 25491945 [TBL] [Abstract][Full Text] [Related]
37. Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia. Yamato G; Yamaguchi H; Handa H; Shiba N; Kawamura M; Wakita S; Inokuchi K; Hara Y; Ohki K; Okubo J; Park MJ; Sotomatsu M; Arakawa H; Hayashi Y Genes Chromosomes Cancer; 2017 Nov; 56(11):800-809. PubMed ID: 28710806 [TBL] [Abstract][Full Text] [Related]
38. The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse. Kurosawa S; Yamaguchi H; Yamaguchi T; Fukunaga K; Yui S; Kanamori H; Usuki K; Uoshima N; Yanada M; Takeuchi J; Mizuno I; Kanda J; Okamura H; Yano S; Tashiro H; Shindo T; Chiba S; Tomiyama J; Inokuchi K; Fukuda T Int J Hematol; 2020 Aug; 112(2):200-209. PubMed ID: 32495317 [TBL] [Abstract][Full Text] [Related]
39. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia. Shamaa S; Laimon N; Aladle DA; Azmy E; Elghannam DM; Salem DA; Taalab MM Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998 [TBL] [Abstract][Full Text] [Related]
40. Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. Baldus CD; Martus P; Burmeister T; Schwartz S; Gökbuget N; Bloomfield CD; Hoelzer D; Thiel E; Hofmann WK J Clin Oncol; 2007 Aug; 25(24):3739-45. PubMed ID: 17646667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]